PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
11-Dec-2024 Ariceum Therapeutics and NorthStar Medical Radioisotopes Announce Supply Agreement for Therapeutic Radioisotope Actinium-225 Ariceum Therapeutics
10-Dec-2024 Kling Biotherapeutics Strengthens Leadership Team to Advance Pipeline Using its Proprietary Primary B-Cell Selection and Evolution Platform Kling Biotherapeutics
10-Dec-2024 Molecular Diagnostics Market 2021-2028: A Deep Dive into Growth Opportunities and Challenges Transparency Market Research
09-Dec-2024 Wobble Genomics’ Technology Demonstrates Potential in Accelerating Precision Medicine Innovations Wobble Genomics
09-Dec-2024 Carta Healthcare to Power Oncology Research and Clinical Trials with Acquisition of Realyze Intelligence, a UPMC Enterprises Company Carta Healthcare
09-Dec-2024 Phastar Scoops Prestigious 2024 Scrip Award Phastar
09-Dec-2024 Mestag Therapeutics Announces Licensing of a Novel Inflammatory Disease Target from its RAFT Platform Mestag Therapeutics
09-Dec-2024 CD Genomics Enhances Whole Genome SNP Genotyping Services to Propel Genomic Discoveries CD Genomics
09-Dec-2024 CD Genomics Unveils Cutting-edge Targeted Bisulfite Sequencing to Advance Epigenetic Research CD Genomics
05-Dec-2024 Ariceum Therapeutics and Eckert & Ziegler Sign Global Supply Agreement for the Development of Next-Generation Radiotherapeutics for Precision Cancer Treatments Ariceum Therapeutics
05-Dec-2024 TILT Biotherapeutics Provides Update on International Clinical Trial Progress with Intravenous Delivery Regimen for Cancer Immunotherapies TILT Biotherapeutics
04-Dec-2024 Everest Medicines Announces Positive Results in Preliminary Analysis of Phase 1b/2a Clinical Trial of EVER001, a Novel BTK Inhibitor for the Treatment of Primary Membranous Nephropathy Everest Medicines Limited
04-Dec-2024 Tiziana Life Sciences Expands Phase 2 Clinical Trial for Non-Active Secondary Progressive Multiple Sclerosis to Additional Prestigious U.S. Medical Centers Tiziana Life Sciences
04-Dec-2024 VIVEbiotech Secures Growth Investment from Ampersand Capital Partners to Expand Lentiviral Vector Development and Manufacturing Capabilities VIVEbiotech
04-Dec-2024 Thermosome Initiates Final Dose Level in Phase I Trial of Lead Compound THE001 Thermosome
03-Dec-2024 Veranova Recognized as One of SOCMA’s 25 Companies for Industry-Leading Safety Programs Veranova
03-Dec-2024 Biocair strengthens its customer focus in 2024 and prepares for another year of growth Biocair
03-Dec-2024 Orikine Bio secures €800k in innovation research funding to advance groundbreaking autoimmune disease therapy Andrew Lloyd Associates
03-Dec-2024 Everest Medicines Announces Acceptance of VELSIPITY New Drug Application in Hong Kong Everest Medicines
02-Dec-2024 Maximising returns from Life Science Innovation: Genesis Conference 2024 One Nucleus